Athira Pharma Inc. (ATHA)
NASDAQ: ATHA
· Real-Time Price · USD
0.33
-0.03 (-8.33%)
At close: Jun 09, 2025, 3:59 PM
-8.33% (1D)
| Bid | 0.3 |
| Market Cap | 12.92M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -79.75M |
| EPS (ttm) | -2.06 |
| PE Ratio (ttm) | -0.16 |
| Forward PE | -0.79 |
| Analyst | Hold |
| Ask | 0.37 |
| Volume | 328,146 |
| Avg. Volume (20D) | 572,439 |
| Open | 0.34 |
| Previous Close | 0.36 |
| Day's Range | 0.33 - 0.35 |
| 52-Week Range | 0.22 - 3.67 |
| Beta | 3.03 |
About ATHA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ATHA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ATHA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
-12.01%
Althira Pharma shares are trading lower after the ...
Unlock content with
Pro Subscription
8 months ago
+15.73%
Athira Pharma shares are trading higher after the company announced it will present results from its Phase 2/3 LIFT-AD clinical trial of Fosgonimeton to treat Alzheimer's disease.
4 weeks ago · accessnewswire.com
ATHA Completes Ground Geophysics and Commences 2025 Angilak Diamond Drill Exploration ProgramHIGHLIGHTS The 2025 Angilak Exploration Program will comprise ~10,000 m of diamond drilling with two objectives: Lac 50 Deposit - expansion of the footprint of uranium mineralization. Stepping out alo...
2 months ago · accessnewswire.com
ATHA Energy Announces Closing of Financing for Aggregate Gross Proceeds of $10,000,000NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / April 22, 2025 / ATHA Energy Corp. (TSXV:SASK)(FRA:X5...